JTC Employer Solutions Trustee’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Hold |
6,500
| – | – | ﹤0.01% | 272 |
|
|
2025
Q1 | $14K | Hold |
6,500
| – | – | ﹤0.01% | 282 |
|
|
2024
Q4 | $10K | Hold |
6,500
| – | – | ﹤0.01% | 289 |
|
|
2024
Q3 | $13K | Hold |
6,500
| – | – | ﹤0.01% | 295 |
|
|
2024
Q2 | $23K | Hold |
6,500
| – | – | ﹤0.01% | 277 |
|
|
2024
Q1 | $18K | Hold |
6,500
| – | – | ﹤0.01% | 299 |
|
|
2023
Q4 | $11K | Hold |
6,500
| – | – | ﹤0.01% | 308 |
|
|
2023
Q3 | $7K | Hold |
6,500
| – | – | ﹤0.01% | 327 |
|
|
2023
Q2 | $8K | Hold |
6,500
| – | – | ﹤0.01% | 331 |
|
|
2023
Q1 | $10K | Hold |
6,500
| – | – | ﹤0.01% | 332 |
|
|
2022
Q4 | $16K | Hold |
6,500
| – | – | ﹤0.01% | 328 |
|
|
2022
Q3 | $27K | Hold |
6,500
| – | – | ﹤0.01% | 251 |
|
|
2022
Q2 | $18K | Hold |
6,500
| – | – | ﹤0.01% | 243 |
|
|
2022
Q1 | $37K | Hold |
6,500
| – | – | ﹤0.01% | 226 |
|
|
2021
Q4 | $59K | Hold |
6,500
| – | – | 0.01% | 203 |
|
|
2021
Q3 | $70K | Hold |
6,500
| – | – | 0.01% | 191 |
|
|
2021
Q2 | $101K | Buy |
+6,500
| New | +$101K | 0.01% | 162 |
|